selectiveAccumulationOfOsteopontinAndInVivo
limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
historyOfBreast-conservingSurgery
cohortOfPatientsWithAdenomasInOutpatientClinic
diagnosticSensitivityForWomenWithDenseBreasts
intravenousAdministration
greater
representativeSignatures
20%IncreasedRisk
variableMechanismsOfCarcinogenesis
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
accomplished
meta-analysis
HenceCurrentlyImplementedInScreeningAtRiskOfBreastCancer
stillNecessaryForAdoptionOfCTnAsRoutineBiomarkerInPatientsWithBreastCancer
familyImpact
betterOutcomeWithGoodValue
HenceCurrentlyOnlyRoutinelyImplemented
complexDisease
definitiveDiagnosis
patientWithHER2
stillNecessaryForAdoptionOfCTnAsBiomarkerInPatientsWithBreastCancer
amount
rareEntityWithOnlyCasesHavingReported
secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
overviewOfBreastMRIProtocols
20%RiskOfBreastCancerAmongCurrentContraceptionUsers
potentialOfAIONAsMultimodalContrastAgentForBreastCancerDiagnosis
thanFamiliesOfPatients
increasedRiskWithUseOfLevonorgestrelSystem-bothOfImportantFindings
years2005-2017
inTumorImaging
commonAgentsUsedInBreastCancerTreatment
assessment
recognized
increasedRiskAmongContraceptionUsers
entityWithOnlyCases
0.004
entityWithFewCasesHavingReported
accumulationOfFluorescentOsteopontinInVitroAnd
TNBCCells
ageThanPatients
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesMainlyWithTrastuzumab
patientsInStudy
diagnosticPerformanceOfPETImagingInPatients
them
theirAbility
accumulationInVitroAndInVivo
differentialDiagnosis
currentlyRoutinelyImplementedInScreeningAtIncreasedRisk
novelClinicalStrategies
associationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
veryRareClinicalEntityWithFewCasesHavingReportedToDate
associationAmongWomenWithBreastCancer
detectionOfBreastCancerInWomen
invasiveBreastCancer
largeCohort
found
familialCancerClusteringInPatients
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithTrastuzumab
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisMainlyWithTrastuzumab
multipleFactors
mechanismsOfCarcinogenesis
HenceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
significantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
HenceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
20%RiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
InConclusionStillNecessaryForAdoption
combinationsOfInductionInBRCA1Wild-typeBreastCancer
theirAbilityOfPrognosisPrediction
accumulatedDoseOfTreatment
currentlyImplementedInScreeningOfWomenAtRiskOfBreastCancer
PARPTreatments
HenceOnlyRoutinelyImplemented
underutilized
confidenceIntervals
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsWithTrastuzumab
mustAddressed
higherRiskForMalignancy
HenceImplementedInScreeningAtRisk
stillNecessaryForAdoptionAsClinicalBiomarkerInPatients
20%IncreasedRiskOfBreastCancer
onlyRoutinelyImplementedInScreeningAtIncreasedRisk
alsoShaped
treatment
maySmall
formedByCo-encapsulationOfFluorophoreInMicelles
evidenceForAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
evidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
PETProbe68Ga-Pentixafor
potentialAsContrastAgentForBreastCancerDiagnosis
veryRareEntityWithOnlyFewCases
feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterTissueSampling
toolForTargetedTreatmentOfCancerIncludingBC
currentlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
confirmationUsingNearInfraredImaging
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
18F-FDGPET
HenceImplementedInScreeningAtIncreasedRiskOfBreastCancer
variableMolecularMechanisms
At25HPost-injectionGreaterInTumorBedRespectively
clinicalBiomarkerInPatients
largelyConsistent
necessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
54%
riskWithUse
largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAlone
HenceOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesWithTrastuzumab
strongContrastWithImagingModalities
preciseToolForTreatmentIncludingBC
effectiveDiagnosisOfBreastCancer
BRCA1Wild-typeTNBCCells
results
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationWithTrastuzumab
selectedCasesWithNeuromas
haveValidatedByStudiesMainlyWithTrastuzumab
increasedRiskWithUseOfLevonorgestrelSystem-bothOfFindings
betterOutcome
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombination
veryComplexDisease
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesWithTrastuzumab
additionalIndicator
implementedInScreeningOfWomenAtIncreasedRisk
previousDecades
riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfFindings
biomarkerInPatientsWithBreastCancer
stillNecessaryForAdoptionAsRoutineBiomarker
necessaryForAdoptionOfCTnAsBiomarker
haveValidatedMainlyWithTrastuzumab
confirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
performance
InConclusionNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
heterogeneousCancerInFemalePatients
abbreviatedMRIProtocols
InConclusionNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
second
InConclusionNecessaryForAdoptionAsRoutineBiomarker
evidencedByIncrease
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
molecularMechanisms
rareEntityWithCases
outcome
SUVmax
subcutaneousBreastTumorInNudeMice
HenceCurrentlyImplementedInScreeningAtRisk
outcomeOverCosts
selectiveAccumulationOfOsteopontin
recorded
veryRareCase
InConclusionStillNecessaryAsClinicalBiomarker
CXCR4ExpressionDeterminedByImmunohistochemistry
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfImportantFindings
20%RiskOfBreastCancer
HenceCurrentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
herEjectionFraction
HenceImplementedInScreeningAtRiskOfBreastCancer
specificCancerCell-relatedComponents
anti-HER2Treatment
continuing
entityWithCases
performanceOfPETImaging
reportedInProportionOfPatientsWithPA
combinations
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedMainlyWithTrastuzumab
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
infraredImagingInTripleNegativeInVitro
veryRareEntityWithOnlyCasesHavingReported
significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
riskOfBreastCancerAmongHormonalContraceptionUsers
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
randomEffectsModel
performanceOfCXCR4-directedPETImagingInPatients
increasedRiskAmongHormonalContraceptionUsers
20%IncreasedRiskAmongCurrentHormonalContraceptionUsers
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
earlyDiagnosisOfCardiotoxicity
veryRareEntityWithOnlyFewCasesHavingReported
postmenopausalPatient
BRD4Regulation
biomarker
InConclusionStillNecessaryForAdoptionOfCTnAsClinicalBiomarkerInPatients
secondaryConfirmationOfSignalAccumulationUsingNearInfraredImaging
routineBiomarkerInPatientsWithBreastCancer
useOfAdvancedImagingExaminations
introducedCXCR4-targetedPETProbe68Ga-Pentixafor
potentialAsEffectiveContrastAgent
InConclusionNecessaryForAdoptionOfCTnAsClinicalBiomarkerInPatients
InConclusionStillNecessaryAsClinicalBiomarkerInPatientsWithBreastCancer
typeOfSurgery
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
InConclusionNecessaryForAdoptionOfCTnAsRoutineBiomarker
FurthermoreDiagnosedWithPAAtEarlierAge
presentingWithNeuropathicBreastPain
haveValidatedByStudiesWithTrastuzumab
HenceCurrentlyImplementedInScreeningAtIncreasedRiskOfBreastCancer
currentlyImplementedInScreeningOfWomenAtRisk
effectiveDiagnosis
routineClinicalBiomarkerInPatients
25Months
toolForTreatmentOfCancerIncludingBC
rareEntityWithCasesHavingReported
evidenceForInverseAssociationAmongWomenWithBreastCancer
At25HPost-injectionGreaterThanInKidney
stillNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarkerInPatients
diagnosedWithPAAtEarlierAgeThanPatients
tripleNegativeInVitro
FurthermoreDiagnosedWithPAAtAgeThanPatientsWithNegativeFamilyHistory
useOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
diagnosisOfSyndromes
included
onlyFewCasesHavingReportedToDate
thanFamiliesOfPatientsWithAdenomas
screening
feasibleInCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
humanErrors
HenceOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
limitedEvidenceForAssociationAmongWomenWithBreastCancer
mostSensitiveTestForBreastCancerDetection
significantPrognosticValue
obtained
measured
combinationsOfInductionInBRCA1TripleNegativeBreastCancer
selectiveAccumulationAnd
ThereforeHasAppliedToIdentification
largeCohortOfPatientsWithPituitaryAdenomas
entityWithFewCases
tool
accumulationOfOsteopontinInVitroAnd
GivenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
rareEntityWithFewCases
veryRareEntityWithFewCases
mostCommonCancer
accumulationOfOsteopontinAndInVivo
evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
necessaryForAdoptionAsClinicalBiomarkerInPatients
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombination
feasibleInSelectedCasesAfterAccurateTissueSampling
fiveDosesOfAdjuvantTranstuzumab
veryRareEntityWithOnlyCases
InConclusionStillNecessaryAsBiomarkerInPatients
20%Risk
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
ageThanPatientsWithFamilyHistory
outcomesOfEstrogenPositive
limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-carotene
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationMainlyWithTrastuzumab
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesMainlyWithTrastuzumab
InConclusionStillNecessaryAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
formulationOfEffectiveManagementPlan
feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
HenceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
FurthermoreDiagnosedWithPAAtAge
differentContrastAgent
widerPopulationOfTNBCPatients
increasedRiskOfBreastCancerAmongHormonalContraceptionUsers
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
images
stillNecessaryForAdoptionOfCTnAsClinicalBiomarkerInPatients
otherGenes
selectiveAccumulationOfFluorescentOsteopontinInVitroAnd
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
developedCBCAmong
adoption
diagnosticPerformanceOfCXCR4-directedPETImaging
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
InConclusionNecessaryForAdoptionOfCTnAsBiomarker
potentialOfAIONAsContrastAgentForBreastCancerDiagnosis
woundDrains
theirBeliefs
riskWithUseOfLevonorgestrelSystem-bothOfFindings
betterOutcomeWithPredictiveValue
mechanisms
discovery
due
diagnosisInPatientsWithHistory
stillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
managementOfTumour-relatedSymptoms
presentingWithBreastPain
clinicalEntityWithOnlyFewCasesHavingReportedToDate
refractoryNeuropathicBreastPain
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
InConclusionNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarkerInPatients
selectiveAccumulationInVitroAndInVivo
necessaryForAdoptionAsRoutineBiomarker
HenceRoutinelyImplemented
diagnosisInPatients
newlyIdentified
outcomeWithNegativeValue
limitedEvidenceForSignificantlyInverseAssociationAmongWomenWithBreastCancer
subtype-specificPrognosticSignatures
InConclusionNecessaryForAdoptionOfCTn
specificCancerComponents
flowCytometry
benefits
onlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
InConclusionStillNecessaryForAdoptionOfCTnAsRoutineBiomarker
preciseToolForTreatment
combinationsOfInductionInBRCA1NegativeBreastCancer
veryRareEntityWithCasesHavingReported
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsMainlyWithTrastuzumab
associationBetweenPost-diagnosisUse
modifiedFactor
19
themselves
infraredFluorescentImagingInNegativeInVitro
InConclusionStillNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
HenceRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
region
DNADamageRegulation
presenceOfMetastaticDiseaseAtPresentation
haveValidated
complex
inverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
entityWithOnlyCasesHavingReported
clinicalEntityWithFewCasesHavingReportedToDate
goodNegativePredictiveValue
23Studies
hasMainlyAssociatedWithMutations
visuallyDetectable
previousStudies
useOfImagingExaminations
confirmationUsingNearInfraredFluorescentImaging
56%
recentlyHaveDeveloped
InConclusionStillNecessaryForAdoptionAsClinicalBiomarkerInPatients
subtype-specificSignatures
myocardialInjury
necessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
lowDiagnosticSensitivityForWomenWithDenseBreasts
reportedInProportion
theirBeliefsRegardingCancerCausation
hasAssociatedWithMutationsInBRCA1
InConclusionStillNecessaryAsRoutineBiomarkerInPatients
areInvestigatedForBreastCancerDiagnosis
test
molecularMechanismsOfCarcinogenesis
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneWithTrastuzumab
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
diet
entityWithOnlyFewCasesHavingReported
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfFindings
GivenConcernsAreInvestigatedForBreastCancerDiagnosis
glycosylationOfMembraneTypeMR
therapeuticBenefits
ourPreliminaryMolecularBiologyExperimentData
increasedRiskWithUse
cancerInPatientsWorldwide
earlierAgeThanPatients
currentlyImplemented
implemented
preciseToolForTargetedTreatmentIncludingBC
associationBetweenIntakeOfB-carotene
greaterInTumorBedThanInKidneyRespectively
cohortOfPatientsWithAdenomas
performanceInPatientsWithBreastCancer
additionalAnti-HER2Therapy
outcomesOfEstrogenReceptorPositive
InConclusionNecessaryAsBiomarkerInPatients
heterogeneousCancerInPatients
NAC
BRCAnessPhenotypeInBRCA1Wild-typeTNBCCells
protected
widerPopulation
HenceCurrentlyImplementedInScreeningAtIncreasedRisk
cardiotoxicityDiagnosis
updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery
strongFactor
mammography
feasibleInSelectedCasesWithNeuromasAfterTissueSampling
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
haveValidatedWithTrastuzumab
outcomeWithGoodNegativePredictiveValue
life
cohortOfPatients
accumulationOfOsteopontin
implementedInScreeningOfWomenAtRiskOfBreastCancer
hasMainlyAssociatedWithMutationsInBRCA1
comparedSemi-quantitatively
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
increase
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationWithTrastuzumab
BRCA1Wild-typeTripleNegativeBreastCancer
theirExperiencesLiving
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
IORT
betterOutcomeWithGoodNegativePredictiveValue
harmfulorTissues
diagnosticPerformanceInPatients
hasAssociated
diagnosticSensitivity
hazardRatios
elderlyPatient
InConclusionStillNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarkerInPatients
825Ml
HenceOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
systemicTherapy
mostInvasiveDisease
NotablyDesigned
haveDeveloped
associationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
sensitive
performed
recurrentDisease
mostCommonAgents
majorConcerns
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
onlyRoutinelyImplementedInScreeningAtRisk
misdiagnosis
significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
currentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
routineBiomarker
mayIndicativeOfLesion
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
patientsWithLABC
historicallyInvolved
fiveDoses
bindingToBreastCancerCells
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDoses
sensitiveTest
type
meanSUVmaxOf35
rareClinicalEntityWithCasesHavingReportedToDate
stillNecessaryForAdoptionAsBiomarker
strongFamilyHistoryOfCancer
strongIndependentPrognosticFactor
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisWithTrastuzumab
rareEntityWithFewCasesHavingReported
increasedRiskOfBreastCancerAmongContraceptionUsers
InConclusionNecessaryForAdoptionAsBiomarker
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclines
diagnosedWithPAAtAgeThanPatientsWithFamilyHistory
accurateTissueSampling
variableMolecularMechanismsOfCarcinogenesis
clinicalEntityWithOnlyCasesHavingReportedToDate
InConclusionStillNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
selectiveAccumulationOfOsteopontinInVitroAnd
rareClinicalEntityWithOnlyCasesHavingReportedToDate
InConclusionNecessaryForAdoptionOfCTnAsRoutineBiomarkerInPatientsWithBreastCancer
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationWithTrastuzumab
BRCA1Levels
necessaryForAdoptionOfCTnAsRoutineBiomarker
HenceCurrentlyRoutinelyImplemented
InConclusionStillNecessaryForAdoptionOfCTnAsBiomarker
InConclusionNecessaryAsClinicalBiomarker
toolForTreatmentOfCancer
enhancementOfImage
HoweverUnderutilized
secondaryConfirmationUsingNearInfraredFluorescentImaging
sensitivityForWomen
rareClinicalEntity
HenceRoutinelyImplementedInScreeningOfWomenAtRisk
oneYearWithoutDeterioration
riskAmongContraceptionUsers
significantlyInverseAssociationAmongWomenWithBreastCancer
currentlyOnlyRoutinelyImplementedInScreeningAtRisk
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
issuesOfExistingContrastAgents
evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
associationBetweenPost-diagnosisLow-doseAspirinUse
status
GivenConcernsAboutContrastAgentsAreInvestigated
recentlyIntroducedCXCR4-targetedPETProbe68Ga-Pentixafor
advancedImaging
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclines
lowSensitivityForWomenWithBreasts
HenceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
20%RiskAmongCurrentContraceptionUsers
feasibleInSelectedCasesWithNeuromasAfterAccurateTissueSampling
veryRareClinicalEntityWithCasesHavingReportedToDate
diagnosisOfAcuteSyndromes
enhancement
patientWithRelapsedHER2
InConclusionStillNecessaryForAdoptionOfCTnAsRoutineBiomarkerInPatientsWithBreastCancer
20%IncreasedRiskOfBreastCancerAmongCurrentContraceptionUsers
evidenceForSignificantlyInverseAssociationAmongWomenWithBreastCancer
total
associationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
InConclusionNecessaryAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
estimated
HenceRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
currentlyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
responsible
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreated
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
InConclusionStillNecessaryAsRoutineClinicalBiomarker
inverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
presenceOfDisease
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
tissueSampling
thesuspiciousRegion
fluorescentImaging
intravenousAdministrationOfOsteopontin-750Probe
veryRareEntityWithCases
InConclusionNecessaryForAdoption
necessaryForAdoptionAsBiomarker
rareEntityWithOnlyFewCases
LABC
detectionInWomen
amongThemNewlyIdentifiedInStudy
currentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
differentBiomarkers
properlySelectedCasesWithAsymptomaticNeuromas
BETInhibitorsAvailableInClinic
InConclusionStillNecessaryForAdoptionOfCTnAsBiomarkerInPatientsWithBreastCancer
InConclusionNecessaryAsRoutineClinicalBiomarker
cancerClusteringInPatientsWithProlactinoma
HenceCurrentlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
onlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
medianFollow-upOf48Years
entityWithCasesHavingReported
sensitivityForWomenWithBreasts
associationBetweenAspirinUse
mustAddressedDuringCancerCounselingConsultations
formulation
commonAgentsUsed
feasibleInSelectedCasesAfterTissueSampling
stillNecessaryForAdoptionOfCTnAsRoutineBiomarker
rareClinicalEntityWithOnlyFewCasesHavingReportedToDate
inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
developed
familyHistory
formulationOfManagementPlanForWomen
feasibleInCasesWithAsymptomaticNeuromasAfterTissueSampling
infraredImagingInNegativeInVitro
imagingInTripleNegative
necessaryForAdoptionOfCTnAsBiomarkerInPatientsWithBreastCancer
necessaryForAdoptionOfCTnAsClinicalBiomarkerInPatients
diagnosticPerformanceOfCXCR4-directedPETImagingInPatientsWithBreastCancer
lungCancerInHuman
At25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
rareEntityWithOnlyCases
ourPreliminaryBiologyExperimentData
currentlyRoutinelyImplementedInScreeningAtRisk
malign
areAlsoInvestigated
therapeuticApproachesEspeciallyUnderViewOfCurrentDevelopments
riskAmongHormonalContraceptionUsers
analysis
InConclusionStillNecessaryForAdoptionAsRoutineBiomarker
routinelyImplementedInScreeningAtRiskOfBreastCancer
20%RiskAmongCurrentHormonalContraceptionUsers
updateOnRiskFactorsForSeromaProduction
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneWithTrastuzumab
performanceOfPETImagingInPatientsWithBreastCancer
clinicalStrategies
outcomeWithGoodValue
casesWithAsymptomaticNeuromas
associationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
potentialOfAIONAsEffectiveMultimodalContrastAgent
veryRareClinicalEntityWithOnlyCasesHavingReportedToDate
stillNecessaryForAdoptionOfCTnAsBiomarker
potential
accumulationAnd
limitedEvidenceForInverseAssociationAmongWomenWithBreastCancer
outcomeWithPredictiveValue
agents
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationWithTrastuzumab
analyzed
commonlyDiagnosed
strongIndependentFactor
HenceRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
inverseAssociationBetweenPrediagnosisIntakeOfB-carotene
secondaryConfirmationUsingNearInfraredImaging
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDoses
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
ourMolecularBiologyExperimentData
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesMainlyWithTrastuzumab
InConclusionStillNecessaryForAdoptionAsBiomarker
veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
entityWithOnlyFewCases
familyMemberAffectedWithCancer
evidenceForAssociationAmongWomenWithBreastCancer
evidencedByIncreaseInContrastAfterInjection
potentialOfAIONAsEffectiveContrastAgent
earlierAgeThanPatientsWithFamilyHistory
dualApproach
reportedInSignificantlyHigherProportionOfPatients
severalRepresentativeGene-expression-basedSignatures
disease
representativeGene-expression-basedSignatures
hasAppliedToIdentification
evaluatedInVivo
amountOfVariation
adoptionOfCTn
GivenConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigated
InConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
consistent
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombination
rareEntityWithOnlyFewCasesHavingReported
InConclusionNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombination
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosis
conventionalImaging
evidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
lowSensitivityForWomen
bindingInVitro
fluorescentImagingInNegative
implementedInScreeningOfWomenAtRisk
differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
case
variableMechanisms
60Years
oneYearOfDiseaseControlWithoutDeterioration
riskOfBreastCancerAmongContraceptionUsers
121%OfPatientsWithProlactinomas
inverseAssociationAmongWomenWithBreastCancer
mayUsed
metastaticDiseaseOnPresentation
combinationsOfInduction
fluorescentDye
necessaryForAdoptionOfCTnAsRoutineBiomarkerInPatientsWithBreastCancer
thanFamiliesOfPatientsWithNon-functioningAdenomas
femaleSibling
severalRepresentativeSignatures
cancerInFemalePatientsWorldwide
presenceAtPresentation
evidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
20%IncreasedRiskAmongCurrentContraceptionUsers
accumulationOfFluorescentOsteopontin
strongPrognosticFactor
GivenConcernsAboutContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
formedByCo-encapsulationOfNear-infraredFluorophoreInMicelles
ourExperience
physicalFinding
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
selectiveAccumulationOfFluorescentOsteopontin
infraredFluorescentImagingInTripleNegativeInVitro
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationMainlyWithTrastuzumab
homologousRecombination-mediatedDNARepair
InConclusionNecessaryForAdoptionOfCTnAsBiomarkerInPatientsWithBreastCancer
administration
reserved
evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
dose-dependentReduction
cancerComponents
treatmentOptions
lowDiagnosticSensitivity
GivenRecentConcernsAboutContrastAgentsAreAlsoInvestigated
ThusWouldCrucial
InConclusionNecessaryAsClinicalBiomarkerInPatientsWithBreastCancer
theirOriginallyTargetedPopulationsOfBreastCancer
wouldCrucial
apoptosis
reductionInBRCA1Levels
veryRareClinicalEntity
potentialAsEffectiveMultimodalContrastAgent
independent
veryRareEntityWithFewCasesHavingReported
375%
necessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
imaging
issues
InConclusionNecessaryForAdoptionAsClinicalBiomarkerInPatients
subcutaneousBreastTumorInMice
limitedEvidenceForAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
rareCase
rareClinicalEntityWithFewCasesHavingReportedToDate
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAlone
previousBreast/axillarySurgery
20%IncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
BETInhibitorsAlreadyAvailableInClinic
haveValidatedByStudies
stillNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
diagnosisProcess
BETInhibitors
neuralNetworkClassifier
AsResultAreUsed
DNADamage
betterOutcomeWithNegativeValue
necessaryForAdoptionOfCTnAsRoutineClinicalBiomarkerInPatients
cellCycleRegulators
imagingInNegative
medicalConsultation
GivenRecentConcernsAboutContrastAgentsAreInvestigatedForBreastCancerDiagnosis
currentlyImplementedInScreeningOfWomenAtIncreasedRisk
combinationsOfInductionInBRCA1Wild-typeTripleBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesWithTrastuzumab
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesMainlyWithTrastuzumab
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
allFiveCases
safetyIssues
mutationalStatus
formulationOfEffectiveManagementPlanForAt-riskWomen
inverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
follow-upOf48Years
routinelyImplementedInScreeningAtIncreasedRisk
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombination
cancerClustering
refractoryBreastPain
associationBetweenPrediagnosisDietaryIntakeOfB-carotene
tumorBed
diagnosisOfResponseToTreatment
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
diagnosed
InConclusionNecessaryAsRoutineBiomarkerInPatients
accumulationOfFluorescentOsteopontinAndInVivo
involvedInDNADamageRegulation
GivenConcernsAreAlsoInvestigated
associationBetweenPost-diagnosisAspirinUse
GivenRecentConcernsAboutGadolinium-basedContrastAgentsAreInvestigated
HenceOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
currentlyOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
selectedCases
associationBetweenPrediagnosisIntakeOfB-carotene
established
contrastAgents
cohortOfPatientsInOutpatientClinic
diagnosedWithPAAtEarlierAgeThanPatientsWithFamilyHistory
effectiveTechniqueused
associationBetweenUse
hasMainlyAssociated
formedByCo-encapsulationInMicelles
potentialOfAION
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatients
typeOfPA
additionalTherapy
3.5
confirmationOfSignalAccumulationUsingNearInfraredImaging
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombination
higherRisk
riskWithUseOfLevonorgestrelSystem-bothOfImportantFindings
routinelyImplementedInScreeningAtRisk
evidenceForAssociationBetweenPrediagnosisIntakeOfB-carotene
significantValue
correspondingCohort
fluorescent
hasFound
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
121%OfPatients
HenceCurrentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
hasAssociatedWithMutations
prognostic
GivenConcernsAboutGadolinium-basedContrastAgentsAreInvestigatedForBreastCancerDiagnosis
clinicalEntityWithCasesHavingReportedToDate
managementOfSymptoms
toolForTargetedTreatmentOfCancer
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
HenceImplementedInScreeningAtIncreasedRisk
micelles
reportedInHigherProportionOfPatients
preciseToolForTargetedTreatment
familyMemberAffected
implementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
InConclusionStillNecessaryForAdoptionOfCTn
FurthermoreDiagnosedWithPAAtEarlierAgeThanPatientsWithNegativeFamilyHistory
potentialAsMultimodalContrastAgentForBreastCancerDiagnosis
amountOfObservedVariation
currentlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
theirExperiencesLivingWithSister
stillNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
familyMember
GivenRecentConcernsAreAlsoInvestigatedForBreastCancerDiagnosis
clinicalEntity
diagnosedWithPAAtAgeThanPatients
fluorescentImagingInTripleNegative
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesWithTrastuzumab
administrationOfOsteopontin-750Probe
routinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
increaseInContrastAfterInjection
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
summaryHazardRatioOf070ForHighestIntake
radiotherapy
recentlyFound
understand
rare
riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfImportantFindings
selectiveAccumulationOfFluorescentOsteopontinAndInVivo
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
associationBetweenLow-doseAspirinUse
highlyExpressed
approach
GivenRecentConcernsAreInvestigated
directional
HenceCurrentlyRoutinelyImplementedInScreeningOfWomenAtRisk
ourBiologyExperimentData
mayTooSmall
earlyDiagnosis
networkClassifier
preciseTool
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-both
wouldCrucialForApplicationOfPreventiveStrategies
fluorescentImagingInNegativeInVitro
HRs
stillNecessaryForAdoptionOfCTnAsRoutineBiomarkerInPatients
highSensitivity
invasiveDisease
largeCohortOfPatientsInOutpatientClinic
limitedEvidence
performedFromInceptionToJanuary312018
discussed
patientsWithBreastCancerReceiving
currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
patient'sOutcomeOverCosts
independentPrognosticFactor
evidence
necessaryForAdoptionOfCTnAsClinicalBiomarker
diagnosedWithPAAtAgeThanPatientsWithNegativeFamilyHistory
increasedRiskWithUseOfLevonorgestrelSystem-both
differentialDiagnosisInPatientsWithHistory
InConclusionStillNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarker
elderlyPatientWithRelapsedHER2
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationWithTrastuzumab
InConclusionNecessaryForAdoptionOfCTnAsClinicalBiomarker
itsUse
reportedInHigherProportionOfPatientsWithPA
haveValidatedByStudiesInCardiotoxicityDiagnosis
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntake
stillNecessaryForAdoptionOfCTnAsBiomarkerInPatients
InConclusionStillNecessaryAsRoutineBiomarkerInPatientsWithBreastCancer
harmfulorHarmlessTissues
contrastAgent
veryRareClinicalEntityWithCases
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneWithTrastuzumab
breastTumorInMice
familyMembers
rareEntityWithFewCasesHavingReportedToDate
combination
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesWithTrastuzumab
veryRareClinicalEntityWithOnlyCasesHavingReported
HenceCurrentlyOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
MSOT
feasibleInSelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
potentialAsMultimodalContrastAgent
mostSensitiveTest
prognosticValue
HenceCurrentlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
cancerInFemalePatients
one-yearExposureLag
formedByCo-encapsulationOfNear-infraredFluorophoreInPEGylatedMicelles
necessary
co-encapsulationOfNear-infraredFluorophore
imagingInTripleNegativeInVitro
advancedDiagnosticImaging
thanFamilies
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreated
feasibleInProperlySelectedCasesAfterTissueSampling
onlyFewCases
veryRareClinicalEntityWithFewCases
techniqueused
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsWithTrastuzumab
evidenceForAssociationBetweenPrediagnosisIntakeAmongWomen
gene-expression-basedSignatures
confirmationUsingNearImaging
feasibleInSelectedCasesWithAsymptomaticNeuromasAfterTissueSampling
associationBetweenPrediagnosisIntakeAmongWomen
medianFollow-up
inverseAssociationBetweenPrediagnosisDietaryIntake
haveValidatedByStudiesInCardiotoxicityDiagnosisMainlyWithTrastuzumab
differentiallyExpressed
neuropathicBreastPain
properlySelectedCasesWithNeuromas
oneYearWithoutDeteriorationInHerEjectionFraction
farHasAssociatedWithMutations
stillNecessaryForAdoptionAsClinicalBiomarker
associationBetweenPrediagnosisDietaryIntakeAmongWomen
ThereforeHasApplied
currentUsersOfLongerDuration
evidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
InConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
reportedInSignificantlyHigherProportionOfPatientsWithPA
moreCommonlyDiagnosed
associationBetweenUseOfLow-doseAspirin
theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulations
management
WhenPresent
feasibleInCasesAfterTissueSampling
outcomeWithGoodPredictiveValue
mostCommonAgentsUsed
HenceImplementedInScreeningOfWomenAtRisk
diagnosticPerformanceOfCXCR4-directedPETImagingInPatients
biomarkerInPatients
PARPInhibitors-basedTreatments
combinationsOfInductionInBRCA1Wild-typeTripleNegativeBreastCancer
studies
phantomImaging
presenceOfMetastaticDisease
confirmationOfSignalAccumulationUsingNearFluorescentImaging
rareClinicalEntityWithCasesHavingReported
GivenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigated
limitations
diagnosedWithPAAtAge
outcomes
inception
theirAbilityOfPrognosisPredictionInTheirTargetedPopulationsOfBreastCancer
denseBreasts
necessaryForAdoptionAsBiomarkerInPatients
reportedInSignificantlyHigherProportion
fluorescentImagingInTripleNegativeInVitro
CXCR4-targetedPETProbe68Ga-Pentixafor
needed
associationBetweenUseOfAspirin
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
onlyRoutinelyImplementedInScreeningOfWomenAtRisk
present
severalGene-expression-basedSignatures
glycosylation
20%IncreasedRiskOfBreastCancerAmongHormonalContraceptionUsers
inverseAssociationBetweenPrediagnosisIntakeAmongWomen
selectiveAccumulationAndInVivo
time-varyingPost-diagnosisAspirinUse
confirmationUsing
rareCaseOfTraumaticBreastNeuroma
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclines
infraredFluorescentImaging
ourExperienceOfHigh-doseRadiotherapy
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
imagingModalities
post-diagnosisLow-doseAspirinUse
limitedEvidenceForAssociation
detectable
betterOutcomeWithNegativePredictiveValue
entity
casesWithNeuromas
SoFarHasMainlyAssociatedWithMutationsInBRCA1
indicator
cancerDevelopment
At25HPost-injectionGreaterInTumorBed
limitedEvidenceForSignificantlyInverseAssociation
fourTypesOfBreastCancer
hasApplied
GivenConcernsAboutGadolinium-basedContrastAgentsAreInvestigated
InConclusionNecessaryAsRoutineClinicalBiomarkerInPatients
increasedRisk
presence
GivenConcernsAreInvestigated
trendForLessRadicalSurgicalApproachesInBreastCancerDueBetterUnderstandingOfTumourBiology
confirmed
risk
heterogeneousCancer
necessaryForAdoptionAsClinicalBiomarker
testForBreastCancerDetection
evidenceForAssociationAmongWomen
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
related
increasedRiskOfBreastCancerAmongCurrentContraceptionUsers
routineClinicalBiomarkerInPatientsWithBreastCancer
mayUsedForTumourShrinkagePrior
higher
presenceOfDiseaseAtPresentation
agentsUsed
rareClinicalEntityWithOnlyFewCases
therapy
veryRareClinicalEntityWithCasesHavingReported
consultation
haveIntroduced
HenceOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
implementedInScreeningAtRisk
MRIProtocols
identified
inverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
patient'sOutcome
woundDrainsPlaced
currentlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
InConclusionNecessaryForAdoptionAsRoutineBiomarkerInPatients
significantlyHigherThanInFamilies
rareEntityWithOnlyFewCasesHavingReportedToDate
oneYear
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombination
mainAnalysis
infraredImagingInNegative
wouldCrucialForApplicationOfStrategies
stratified
confirmationOfSignalAccumulation
currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
associationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
involved
lowDiagnosticSensitivityForWomen
evidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
associationBetweenPrediagnosisIntake
cancerClusteringInPatients
InConclusionNecessaryForAdoptionAsClinicalBiomarker
dose-dependentReductionInBRCA1Levels
time-varyingLow-doseAspirinUse
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesMainlyWithTrastuzumab
theirAbilityInTheirOriginallyTargetedPopulationsOfBreastCancer
secondaryConfirmationUsingNearFluorescentImaging
associationAmongWomen
GivenRecentConcernsAreInvestigatedForBreastCancerDiagnosis
riskWithUseOfLevonorgestrelSystem-both
riskAmongCurrentContraceptionUsers
riskOfBreastCancerAmongCurrentContraceptionUsers
aggressiveCourseOfHER2Cancer
relapsedHER2
entityWithOnlyFewCasesHavingReportedToDate
recurrentBreastCancer
age
BRCAnessPhenotypeInBRCA1TNBCCells
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedMainlyWithTrastuzumab
increasedRiskAmongCurrentContraceptionUsers
designed
diagnosticImaging
GivenRecentConcernsAboutContrastAgentsAreInvestigated
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesWithTrastuzumab
historyOfBreastSurgery
theirAbilityOfPrognosisPredictionInTheirPopulationsOfBreastCancer
involvedInCancerDevelopment
potentialOfAIONAsEffectiveContrastAgentForBreastCancerDiagnosis
unresectable
familialCancerClusteringInPatientsWithProlactinoma
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomen
InConclusionStillNecessaryForAdoptionAsBiomarkerInPatients
breastCancerPrognosis
formed
missed
20%RiskOfBreastCancerAmongContraceptionUsers
patientsWithBreastCancerReceivingWithAnthracyclines
infraredFluorescentImagingInTripleNegative
mammographicImages
riskStratification
haveReportedMainlyAfterMastectomy
diagnosisOfBreastCancer
ourExperienceOfRadiotherapy
rareClinicalEntityWithOnlyCases
X-rayMammography
study
mayIndicativeOfBenignLesion
veryRareClinicalEntityWithOnlyCases
required
haveReported
primaryBreastCancer
bindingToBreastCancerCellsInVitro
evidenceForInverseAssociation
inverseAssociationAmongWomen
applied
sensitiveTestForBreastCancerDetection
feasibleInCasesAfterAccurateTissueSampling
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
prognosticSignatures
outcomesOfReceptorPositive
secondaryConfirmationOfSignalAccumulationUsingNearImaging
InConclusionStillNecessaryForAdoptionOfCTnAsBiomarkerInPatients
differentialDiagnosisInPatients
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
nationwideRegistries
fewCases
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
agentsUsedInBreastCancerTreatment
FurthermoreDiagnosedWithPAAtAgeThanPatientsWithFamilyHistory
currentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
InConclusionStillNecessaryForAdoptionAsRoutineBiomarkerInPatients
InConclusionStillNecessaryForAdoptionAsClinicalBiomarker
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
selectiveAccumulationOfOsteopontinAnd
patientsWithHistoryOfBreastSurgery
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
SoFarHasMainlyAssociatedWithMutations
riskOfBreastCancer
HenceImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
hasInconsistent
factor
costOfMRIExamination
outcomeWithNegativePredictiveValue
greaterRespectively
necessaryForAdoptionOfCTnAsRoutineClinicalBiomarker
similar
overview
significantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
diagnosisOfCardiotoxicity
inverseAssociationBetweenPrediagnosisIntake
necessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
clinicalEntityWithFewCasesHavingReported
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombination
rareEntity
confirmationOfSignalAccumulationUsingNearImaging
reportedInHigherProportion
HenceRoutinelyImplementedInScreeningAtIncreasedRisk
betterOutcomeWithGoodPredictiveValue
decreasesInBCMortalityRates
surveillance
riskWithUseOfLevonorgestrelSystem-bothOfPotentiallyImportantFindings
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesWithTrastuzumab
fiveDosesOfTranstuzumab
severalSignatures
processing
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationWithTrastuzumab
InConclusionNecessaryForAdoptionOfCTnAsBiomarkerInPatients
HenceOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
reportedInProportionOfPatients
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAlone
haveValidatedByStudiesInCardiotoxicityDiagnosisWithTrastuzumab
statusBesidesFamilyHistory
BRCAnessPhenotype
effectsModel
confirmationUsingNearFluorescentImaging
courseOfHER2Cancer
potentialAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
associationBetweenPrediagnosisDietaryIntake
itsMinimalSilverIonReleaseProfiles
8/18Cases
InConclusionStillNecessaryAsRoutineClinicalBiomarkerInPatients
stillNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarker
GivenConcernsAboutContrastAgentsAreInvestigatedForBreastCancerDiagnosis
theirExperiences
InConclusionNecessaryForAdoptionOfCTnAsRoutineBiomarkerInPatients
time-varyingPost-diagnosisLow-doseAspirinUse
selectiveAccumulationOfOsteopontinInVitroAndInVivo
wouldCrucialForApplication
evidenceForAssociation
HenceCurrentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
limitedEvidenceForAssociationBetweenPrediagnosisIntakeAmongWomen
ThusWouldCrucialForApplication
association
diagnosticPerformance
SoFarHasAssociatedWithMutations
unresectedLocallyAdvancedBreastCancer
stillNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
necessaryForAdoptionOfCTnAsRoutineBiomarkerInPatients
rareEntityWithOnlyCasesHavingReportedToDate
limitedEvidenceForAssociationBetweenPrediagnosisIntake
diagnosticPerformanceOfPETImagingInPatientsWithBreastCancer
routinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
reported
evaluated
InConclusionStillNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
diagnosedWithPAAtEarlierAge
performanceOfCXCR4-directedPETImaging
GivenConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
hasAppliedToEarlyIdentification
selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
neoadjuvantTreatment
InConclusionStillNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationMainlyWithTrastuzumab
shaped
differentiallyExpressedInFourTypes
entityWithFewCasesHavingReportedToDate
stillNecessary
thematicAnalysis
mostPatientsInStudy
HenceOnlyRoutinelyImplementedInScreeningAtRisk
thanKidney
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDoses
cancerInPatients
InConclusionNecessaryAsClinicalBiomarkerInPatients
stillNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
presenting
implementedInScreeningAtIncreasedRisk
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntake
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAlone
routinelyImplementedInScreeningOfWomenAtIncreasedRisk
greaterInTumorBedThanInKidney
inverseAssociation
mayIndicative
387%
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
diagnosticSensitivityForWomenWithBreasts
post-diagnosisAspirinUse
targetedImmuneCell
expressed
HenceCurrentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
confirmation
differentiallyExpressedInFourTypesOfBreastCancer
InConclusionStillNecessaryForAdoptionOfCTnAsRoutineBiomarkerInPatients
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
finances
mayUsedForTumourShrinkagePriorToSurgery
course
heterogeneousCancerInFemalePatientsWorldwide
currentlyImplementedInScreeningAtRiskOfBreastCancer
routineBiomarkerInPatients
ThusWouldCrucialForApplicationOfPreventiveStrategies
farHasMainlyAssociatedWithMutationsInBRCA1
clinicalEntityWithFewCases
veryRareEntity
haveValidatedByClinicalStudies
GivenConcernsAboutContrastAgentsAreAlsoInvestigated
cohortOfPatientsWithPituitaryAdenomas
limitedEvidenceForInverseAssociationAmongWomen
stillNecessaryForAdoptionAsRoutineBiomarkerInPatients
necessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
high-resolutionImages
updateOnRiskFactors
ageThanPatientsWithNegativeFamilyHistory
copyright
secondaryConfirmation
riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
additional
entityWithCasesHavingReportedToDate
lowSensitivityForWomenWithDenseBreasts
co-encapsulationOfFluorophore
25HPost-injection
inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
entityWithOnlyCasesHavingReportedToDate
formulationOfManagementPlanForAt-riskWomen
HenceImplemented
fourTypes
detectionOfBreastCancer
SoFarHasAssociated
necessaryForAdoptionAsRoutineBiomarkerInPatients
betterOutcomeWithGoodNegativeValue
overviewOfAbbreviatedBreastMRIProtocols
increasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
associationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
aspirinUse
rareClinicalEntityWithOnlyFewCasesHavingReported
121%
HenceCurrentlyImplementedInScreeningOfWomenAtRiskOfBreastCancer
strongFamilyHistory
associationBetweenPost-diagnosisUseOfLow-doseAspirin
toolForTargetedTreatment
used
rareClinicalEntityWithFewCases
combinationsOfInductionInBRCA1TripleBreastCancer
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntake
areInvestigated
HenceCurrentlyImplementedInScreeningOfWomenAtRisk
diagnosticPerformanceInPatientsWithBreastCancer
theirAbilityInTheirTargetedPopulationsOfBreastCancer
accumulationAndInVivo
secondaryConfirmationUsing
finding
breastTumorInNudeMice
feasibleInProperlySelectedCasesWithNeuromasAfterAccurateTissueSampling
veryRareClinicalEntityWithOnlyFewCasesHavingReported
CIs
diagnosisOfResponse
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
riskOfBreastCancerAmongCurrentHormonalContraceptionUsers
SUVmaxOf35
population
performanceOfPETImagingInPatients
significantlyInverseAssociationBetweenPrediagnosisIntake
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntake
independentFactor
low-doseAspirinUse
theirAbilityInTheirTargetedPopulations
decreases
primaryBreastCancerPatientsTreatedBetween01012010
increasedRiskWithUseOfLevonorgestrelSystem-bothOfPotentiallyImportantFindings
clinicalBiomarkerInPatientsWithBreastCancer
implementedInScreeningAtRiskOfBreastCancer
errors
potentialOfAIONAsMultimodalContrastAgent
diagnosisOfAcuteCoronarySyndromes
thanFamiliesOfPatientsWithPituitaryAdenomas
feasibleInCasesWithNeuromasAfterAccurateTissueSampling
accumulationOfOsteopontinInVitroAndInVivo
amountOfObservedVariationInSeromaProduction
formulationOfEffectiveManagementPlanForWomen
follow-up
signatures
lowSensitivity
concerns
theirAbilityInTheirPopulationsOfBreastCancer
significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
rareCaseOfBreastNeuroma
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
transferable
stillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
imagingInvestigations
evidenceForAssociationBetweenPrediagnosisIntake
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntake
tumorImaging
infraredFluorescentDye
inclusionCriteria
GivenConcernsAreAlsoInvestigatedForBreastCancerDiagnosis
mostEffectiveTechniqueused
theirAbilityInTheirPopulations
inconsistentResults
associationBetweenIntake
veryRareCaseOfTraumaticBreastNeuroma
aggressiveCourse
amongThemIdentifiedInStudy
GivenRecentConcernsAreAlsoInvestigated
GivenRecentConcernsAboutContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesMainlyWithTrastuzumab
issuesOfContrastAgents
onlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
InConclusionNecessaryForAdoptionAsRoutineClinicalBiomarker
onlyRoutinelyImplemented
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
HenceCurrentlyImplemented
mustAddressedDuringCancerGeneticCounselingConsultations
geneExpression
reduction
20%IncreasedRiskAmongHormonalContraceptionUsers
axillaryLymphNodeMetastasisOfUnknownPrimary
preclinicalPhase
earlierAgeThanPatientsWithNegativeFamilyHistory
InConclusionNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
positiveFamilyHistoryOfMalignancy
time-varyingAspirinUse
infraredImaging
limitedEvidenceForInverseAssociation
HenceCurrentlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
veryRareEntityWithFewCasesHavingReportedToDate
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesWithTrastuzumab
screeningOfWomen
52
BCMortalityRates
secondaryConfirmationUsingNearImaging
feasibleInProperlySelectedCasesWithNeuromasAfterTissueSampling
stillNecessaryForAdoptionOfCTnAsClinicalBiomarkerInPatientsWithBreastCancer
SoFarHasAssociatedWithMutationsInBRCA1
combinationsOfInductionInBRCA1Wild-typeNegativeBreastCancer
higherThanInFamilies
BRD4RegulationInHomologousDNARepair
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDoses
lowDiagnosticSensitivityForWomenWithBreasts
caseOfBreastNeuroma
performanceOfCXCR4-directedPETImagingInPatientsWithBreastCancer
InConclusionNecessaryForAdoptionAsBiomarkerInPatients
modified
routinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
preciseToolForTargetedTreatmentOfCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
InConclusionNecessaryAsRoutineBiomarkerInPatientsWithBreastCancer
preciseToolForTargetedTreatmentOfCancerIncludingBC
farHasMainlyAssociated
potentialOfAIONAsContrastAgent
riskForMalignancy
clinical
20%RiskOfBreastCancerAmongHormonalContraceptionUsers
breastCancerPatientsSerum
non-ideal
preciseToolForTreatmentOfCancerIncludingBC
only35CasesOfTraumaticBreastNeuromas
asymptomaticNeuromas
FurthermoreDiagnosedWithPAAtAgeThanPatients
InConclusionNecessaryForAdoptionOfCTnAsClinicalBiomarkerInPatientsWithBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombination
stageIIIBreastCaner
InConclusionStillNecessaryAsClinicalBiomarkerInPatients
multipleStudies
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombination
time
InConclusionNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
mostPatients
associationBetweenPost-diagnosisUseOfAspirin
evidenced
breastPain
evidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomen
currentlyImplementedInScreeningAtIncreasedRiskOfBreastCancer
clinicalEntityWithOnlyCases
onlyCases
routinelyImplementedInScreeningOfWomenAtRisk
limitedEvidenceForSignificantlyInverseAssociationAmongWomen
haveValidatedByClinicalStudiesMainlyWithTrastuzumab
HenceOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
feasibleInProperlySelectedCasesAfterAccurateTissueSampling
feasible
increasedRiskAmongCurrentHormonalContraceptionUsers
preciseToolForTreatmentOfCancer
properlySelectedCases
rareClinicalEntityWithOnlyCasesHavingReported
InConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarker
value
PEGylatedMicelles
BETInhibitorsAlreadyAvailable
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
inverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
presentingWithRefractoryNeuropathicBreastPain
ThusWouldCrucialForApplicationOfStrategies
clinicians
theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
model
currentlyRoutinelyImplemented
BRD4RegulationInDNARepair
urgentlyNeeded
sixGlycosylationSites
HoweverNon-ideal
infraredFluorescent
necessaryForAdoptionOfCTnAsClinicalBiomarkerInPatientsWithBreastCancer
howeverLower
BETInhibitorsAvailable
patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction
prognosticFactor
woundDrainsPlacedInBreast
massSpectrometry
diagnosis
update
farHasAssociated
HenceImplementedInScreeningOfWomenAtRiskOfBreastCancer
cohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
detection
potentialAsEffectiveContrastAgentForBreastCancerDiagnosis
stillNecessaryForAdoptionOfCTnAsClinicalBiomarker
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesMainlyWithTrastuzumab
mayUsedForTumourShrinkage
evidenceForInverseAssociationBetweenPrediagnosisIntake
secondaryConfirmationOfSignalAccumulation
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
currentlyRoutinelyImplementedInScreeningOfWomenAtRisk
performanceInPatients
evidenceForInverseAssociationAmongWomen
largeCohortOfPatientsWithAdenomasInOutpatientClinic
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclines
neoadjuvantAnti-HER2Treatment
significantlyInverseAssociationAmongWomen
sensitivity
howeverSignificantlyLower
strong
20%IncreasedRiskOfBreastCancerAmongContraceptionUsers
InConclusionNecessaryAsBiomarkerInPatientsWithBreastCancer
InConclusionNecessaryAsRoutineBiomarker
commonAgents
rareClinicalEntityWithCases
HenceCurrentlyRoutinelyImplementedInScreeningAtIncreasedRisk
selectiveAccumulationOfFluorescentOsteopontinAnd
routinelyImplemented
formulationOfManagementPlan
significantlyLower
combinationsOfInductionInBRCA1BreastCancer
currentlyImplementedInScreeningAtRisk
populationOfTNBCPatients
necessaryForAdoptionAsRoutineClinicalBiomarker
InConclusionStillNecessaryForAdoptionOfCTnAsClinicalBiomarkerInPatientsWithBreastCancer
amountOfVariationInSeromaProduction
GivenRecentConcernsAboutGadolinium-basedContrastAgentsAreInvestigatedForBreastCancerDiagnosis
sensitivityForWomenWithDenseBreasts
selectiveAccumulationInVitroAnd
At25HPost-injectionGreaterInTumorBedThanInKidney
co-encapsulation
farHasMainlyAssociatedWithMutations
neuroma
At25HPost-injectionGreaterThanInKidneyRespectively
infraredFluorescentImagingInNegative
HenceCurrentlyImplementedInScreeningOfWomenAtIncreasedRisk
secondaryConfirmationOfSignalAccumulationUsingNearFluorescentImaging
theirAbilityOfPrognosisPredictionInTheirTargetedPopulations
areUsed
unusual
theirAbilityOfPrognosisPredictionInTheirPopulations
managementOfRecurrentHER2
anti-HER2Therapy
formedByCo-encapsulationInPEGylatedMicelles
farHasAssociatedWithMutationsInBRCA1
novelStrategies
registries
outcomeWithValue
diagnosticSensitivityForWomen
veryRareClinicalEntityWithFewCasesHavingReported
23Cross-sectionalStudies
existingContrastAgents
HenceRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationWithTrastuzumab
potentialAsContrastAgent
cohort
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithTrastuzumab
stillNecessaryForAdoptionAsRoutineClinicalBiomarker
conclusion
familialCancerClustering
rareEntityWithCasesHavingReportedToDate
68Ga-Pentixafor
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationWithTrastuzumab
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
potentialOfAIONAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesMainlyWithTrastuzumab
necessity
subcutaneousBreastTumor
evidencedByIncreaseInContrast
20%RiskAmongHormonalContraceptionUsers
expressedInFourTypesOfBreastCancer
FurthermoreDiagnosedWithPAAtEarlierAgeThanPatients
ageOf25Years
diagnosedWithPAAtEarlierAgeThanPatientsWithNegativeFamilyHistory
femalePatientsWorldwide
necessaryForAdoptionOfCTnAsBiomarkerInPatients
theirAbilityInTheirOriginallyTargetedPopulations
onlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
relativesOfPatientsWithPA
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
20%RiskAmongContraceptionUsers
caseOfTraumaticBreastNeuroma
toolForTargetedTreatmentIncludingBC
strategies
haveReportedAfterMastectomy
significantlyHigherThanInFamiliesOfNFPAPatients
InConclusionNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
only35CasesOfBreastNeuromas
familyHistoryOfCancer
feasibleInCasesWithNeuromasAfterTissueSampling
elderlyPatientWithHER2
significantlyHigher
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
inTermHasFound
osteopontinPeptide
BRD4RegulationInHomologousRecombination-mediatedDNARepair
outcomesOfPositive
negativeFamilyHistory
veryRareEntityWithOnlyCasesHavingReportedToDate
evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
veryRareEntityWithCasesHavingReportedToDate
currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
diagnosticPerformanceOfPETImaging
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
ThereforeHasAppliedToEarlyIdentification
HenceCurrentlyOnlyRoutinelyImplementedInScreeningAtRisk
selectedCasesWithAsymptomaticNeuromas
cases
currentlyImplementedInScreeningAtIncreasedRisk
use
accumulationOfFluorescentOsteopontinAnd
selectiveAccumulation
patientsWithBreastCancer
MoreRecentlyHaveDeveloped
increasedRiskOfBreastCancer
January312018
formedByCo-encapsulationOfFluorophoreInPEGylatedMicelles
stillNecessaryForAdoptionAsBiomarkerInPatients
contrastAfterInjection
compared
imagingInNegativeInVitro
secondaryConfirmationOfSignalAccumulationUsing
commonCancer
available
routineClinicalBiomarker
non-functioningPituitaryAdenomas
decades
largeCohortOfPatients
InConclusionStillNecessaryForAdoptionOfCTnAsClinicalBiomarker
accumulationInVitroAnd
betterOutcomeWithValue
earlierAge
mostCommonAgentsUsedInBreastCancerTreatment
firstDiagnosisOfBreastCancer
clinicalEntityWithCasesHavingReported
95%ConfidenceIntervals
patientsWithProlactinoma
FurthermoreDiagnosedWithPAAtEarlierAgeThanPatientsWithFamilyHistory
particular
exposureLag
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas
limitedEvidenceForAssociationAmongWomen
BRD4RegulationInRecombination-mediatedDNARepair
currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
accumulationOfFluorescentOsteopontinInVitroAndInVivo
recentlyIntroducedPETProbe68Ga-Pentixafor
injury
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntake
currentlyOnlyRoutinelyImplemented
InConclusionStillNecessaryAsBiomarkerInPatientsWithBreastCancer
newValue-basedHealthcareParadigm
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombination
toolForTreatment
itsWidespreadUse
introducedPETProbe68Ga-Pentixafor
onlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
higherThanInFamiliesOfNFPAPatients
FurthermoreDiagnosed
currentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
inLongTermHasFound
areAlsoInvestigatedForBreastCancerDiagnosis
oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction
significantlyInverseAssociationBetweenPrediagnosisDietaryIntake
meanSUVmax
moreDirectional
largeCohortOfPatientsWithAdenomas
managementOfHER2
heterogeneousCancerInPatientsWorldwide
clinicalEntityWithOnlyFewCases
HenceRoutinelyImplementedInScreeningAtRiskOfBreastCancer
7/18Patients
rareClinicalEntityWithFewCasesHavingReported
expressedInFourTypes
InConclusionNecessaryForAdoptionOfCTnAsRoutineClinicalBiomarker
clinicalBiomarker
haveValidatedByClinicalStudiesWithTrastuzumab
mutationalStatusBesidesFamilyHistory
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
20%IncreasedRiskAmongContraceptionUsers
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneWithTrastuzumab
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntake
HenceImplementedInScreeningOfWomenAtIncreasedRisk
diagnosisOfCoronarySyndromes
isIn
evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
toolForTreatmentIncludingBC
InConclusionStillNecessaryAsRoutineBiomarker
historyOfTranstuzumab-inducedCardiacDysfunction
latestTreatmentOptions
riskWithUseOfLevonorgestrelIntrauterineSystem-both
outpatientClinic
evidenceForAssociationBetweenPrediagnosisDietaryIntake
InConclusionStillNecessaryAsBiomarker
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatients
confirmationOfSignalAccumulationUsing
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsMainlyWithTrastuzumab
InConclusionNecessaryAsBiomarker
patientsWithPrimaryBreastCancer
veryRareCaseOfBreastNeuroma
clinicalEntityWithCases
traumaticNeuroma
accumulation
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntake
infraredImagingInTripleNegative
lapatinibCombined
generallyReserved
smallPatientCohort
riskAmongCurrentHormonalContraceptionUsers
evidenceForSignificantlyInverseAssociationAmongWomen
necessaryForAdoptionOfCTnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
oneYearOfDiseaseControl
HenceCurrentlyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
evidenceForSignificantlyInverseAssociation
contrastWithImagingModalities
platinumSalts
veryRareEntityWithOnlyFewCasesHavingReportedToDate
developedCBCDuring
outcomeWithGoodNegativeValue
binding
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationMainlyWithTrastuzumab
presentingWithRefractoryBreastPain
HenceRoutinelyImplementedInScreeningAtRisk
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombination
implementedInScreeningAtIncreasedRiskOfBreastCancer
veryRareClinicalEntityWithOnlyFewCases
benign
increaseInContrast
diagnosisInPatientsWithHistoryOfBreastSurgery
SoFarHasMainlyAssociated
significantlyInverseAssociation
clinicalEntityWithOnlyFewCasesHavingReported
accumulationOfOsteopontinAnd
only35Cases
lower
clinicalEntityWithOnlyCasesHavingReported
HenceCurrentlyRoutinelyImplementedInScreeningAtRisk
25MonthsFromDiagnosis